Therapeutic Effects of Curcumin as Supplement on Metabolic Syndrome

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 90

Inclusion Criteria

The main including criteria:
Filling the consent form of the present project in the beginning of study; lack of any kinds of chronic diseases such as diabetes, renal diseases, tuberculosis, liver diseases and/or the history of cardiac surgery; possessing at least 3 items of all the 5 indexes of metabolic syndrome (based on the definition by NCEP ATP III) (in case of insulin resistance, patients must have fasting blood glucose less than 126 mg/dL, otherwise these patients diagnosed as diabetic patients and must have exclude from the study); lack of taking medicine to control blood glucose, blood lipid and hypertension; the age range between 25 to 65 year; lack of injecting insulin so as to blood glucose control.

The main exclusion criteria:
Lack of regular taking the given supplements; lack of following the given diet which evaluated by the analysis of 3 days recall questionnaire by using Nutritionist- 4 software; starting taking medicine or supplements that may be affect the results of test of investigated factors or oral contraceptives, estrogen, progesterone and corticosteroids; pregnancy; taking/receiving insulin or tablet to control the blood glucose; losing any of inclusion criteria during the time of conducting the study.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma Glucose. Timepoint: base line and aftar 3 months of begin. Method of measurement: in term of mg/ dL by biochemical kits.;Blood pressure. Timepoint: base line, at the end of 6th week and aftar 3 months of begin. Method of measurement: in term of mm Hg by Mercury barometers.;Plasma HDL-C. Timepoint: base line and aftar 3 months of begin. Method of measurement: in term of mg/ dL by biochemical kits.;Plasma TG. Timepoint: base line and aftar 3 months of begin. Method of measurement: in term of mg/ dL by biochemical kits.;Waist Circumference. Timepoint: base line, at the end of 6th week and aftar 3 months of begin. Method of measurement: in term of centimeter by Tape measure.

Secondary Outcome Measures

Name	Time	Method
Total Cholesterol. Timepoint: baseline and after 3th month. Method of measurement: in term of mg/ dL, by using biochemical kits.;LDL-C. Timepoint: baseline and after 3th month. Method of measurement: in term of mg/ dL, by using biochemical kits.;Body Fat Mass. Timepoint: baseline, at the end of 6th week and after 3th month. Method of measurement: in term of kg, by usig body analyser instrument.;Body Fat Free Mass. Timepoint: baseline, at the end of 6th week and after 3th month. Method of measurement: in term of kg, by usig body analyser instrument.;Body Mass Index (BMI). Timepoint: baseline, at the end of 6th week and after 3th month. Method of measurement: in term of kg/ m2.;Weight. Timepoint: baseline, at the end of 6th week and after 3th month. Method of measurement: in term of kg by using standardized scale.